Echolight.it

What Echolight.it does

Echolight S.p.A. is an Italy-based medical device company founded in 2010 as a spin-off of the Italian National Research Council (CNR) that has developed the proprietary R.E.M.S. (Radiofrequency Echographic Multi Spectrometry) technology - an ultrasound-based, radiation-free method for assessing bone mineral density and microarchitectural quality at the lumbar vertebrae and proximal femur. Its product platform comprises five hardware configurations (EchoS, EchoS Plus, EchoStation, EchoHybrid, and EchoHybrid Plus) bundled with the EchoStudio software suite, which delivers modules for Bone Density, Body Composition, Fragility Score, 5-year Fracture Risk, Skeletal, and Gynecology assessments, paired with interchangeable Convex, Linear, and Endocavity probes. Clinical differentiation rests on the patented Fragility Score (a 0-100 dimensionless index of bone quality independent of BMD), automatic artifact rejection, rapid 40-80 second scans, and a proprietary reference database of 15,000+ subjects validated in multicenter studies.

Echolight monetizes through a hybrid model: one-time sales of bone densitometry hardware under multi-year contracts, recurring EchoStudio software licenses (annual or perpetual), and accessories/probes, distributed globally through 40+ medical device distributors and direct sales operations in Italy (Lecce) and the US (Seattle, Houston, Kenmore). Target buyers include hospitals, specialty clinics, primary care practices, community pharmacies, wellness centers, and home-care settings - including populations typically contraindicated for X-ray-based densitometry such as pregnant women, children, and oncology or diabetes patients. Commercial expansion is supported by FDA 510(k) clearance (2017), CE mark, ISO 13485:2016 and ISO 9001:2015 certifications, inclusion in Italian ISS guidelines (2020) and Polish national osteoporosis recommendations (2026), and a dedicated AMA/CMS CPT code for REMS in the US (2023), alongside research collaborations including NASA for spaceflight bone-loss monitoring.

Revenue is not publicly disclosed; the company has raised disclosed external equity from Life Science Capital S.p.A. (2011) and a Series A co-led by Panakès Partners and Invitalia Ventures (2015/2016), with operations spanning Europe, North America, the Middle East, Latin America, and Asia-Pacific under the leadership of founder and CEO Sergio Casciaro.

Name

Echolight.it

Legal name

Echolight S.p.A.

Website

https://echolightmedical.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Echolight S.p.A. is an Italian medical device company that sells the proprietary R.E.M.S. ultrasound technology, delivering radiation-free bone density and Fragility Score assessments at the lumbar spine and femur for hospitals, clinics, primary care, pharmacies, wellness centers, and home-care settings via a global network of 40-plus distributors.

Ownership category

akta.pro rank

Product category

Medical Imaging / Bone Densitometry Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro industry

PRIMARYHLAHABAD

Ultrasound & Echography Systems

Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

• Bone densitometry devices
• Radiation-free ultrasound imaging
• Osteoporosis diagnostic equipment
• Medical imaging hardware
• Fragility fracture assessment

Headquarters

HQ city

Lecce

HQ country

Italy

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. EchoS Hardware Devices: Sale of bone densitometry hardware devices including EchoS (portable unit with laptop), EchoStation (clinical configuration), EchoHybrid and EchoHybrid Plus (cart-based versatile configurations). Each device includes main ultrasound unit, carrying case, and accessories. Multiple hardware tiers address different clinical settings from home care to hospitals.
2. EchoStudio Software Licenses: Annual or perpetual licenses for EchoStudio software applications providing bone density, body composition, fragility score, fracture risk, skeletal, and gynecology assessments. Software can be configured based on clinical needs with matched probes (Convex, Linear, Endocavity).

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Echolight designs, manufactures, and sells radiation-free ultrasound-based bone densitometry devices (EchoS, EchoS Plus, EchoStation, EchoHybrid, EchoHybrid Plus) powered by its proprietary R.E.M.S. technology for early osteoporosis diagnosis, fragility fracture risk assessment, body composition analysis, and gynecological/musculoskeletal ultrasound evaluations. The hardware is paired with the EchoStudio software suite licensed annually or perpetually to clinical customers including hospitals, clinics, pharmacies, wellness centers, and home-care providers across more than 40 countries.

Product overview

Echolight offers a unified bone health assessment platform centered on the proprietary R.E.M.S. (Radiofrequency Echographic Multi Spectrometry) technology. The hardware portfolio comprises five EchoS device configurations — EchoS (portable), EchoS Plus, EchoStation, EchoHybrid, and EchoHybrid Plus — which are ultrasound-based bone densitometers delivering radiation-free assessment at lumbar vertebrae and femoral neck. The software suite includes ECHOSTUDIO modules (Bone Density, Body Composition, Fragility Score, Fracture Risk, Skeletal, and Gynecology) running on the device hardware, with interchangeable probes (Convex, Linear, Endocavity) for different clinical applications. EchoS serves primary care, clinics, hospitals, pharmacies, and home care settings, while EchoStation targets fixed clinical installations. The platform integrates hardware and software into a complete bone health identity solution.

Differentiator

Problem solved

Functional benefit

Brands

• EchoS: The only radiation-free ultrasound bone densitometer for assessing bone health at the lumbar vertebrae and femoral neck using R.E.M.S. technology
• EchoStation
• EchoHybrid
• EchoStudio
• R.E.M.S.

Products and services

• EchoS Portable radiation-free ultrasound bone densitometer using R.E.M.S. technology for assessing bone condition at lumbar vertebrae and femoral neck. Available with USB-connected laptop for use in hospitals, clinics, pharmacies, and home care.
• EchoS Plus Enhanced portable configuration of the EchoS bone densitometer with upgraded specifications, designed for hospitals, clinics, pharmacies, and home care use with maximum versatility.
• EchoStation Dedicated clinical workstation configuration for hospitals and clinics providing an integrated bone density assessment solution using REMS technology.
• EchoHybrid Hybrid cart-based configuration for clinical centers and remote locations, combining the main ultrasound unit with a cart, medical PC, laptop, and hard carrying case for transport versatility.
• EchoHybrid Plus Maximum versatility configuration including main ultrasound unit, cart and medical PC, and hard carrying case with integrated PC for the most flexible deployment options across clinical settings.
• EchoStudio Bone Density Software module for assessment of bone mineral density at lumbar vertebrae (L1-L4) and femoral neck, providing BMD (g/cm2), T-Score, and Z-Score parameters for osteoporosis diagnosis.
• EchoStudio Body Composition Software module for body composition analysis during ultrasound scan, providing BMI, percentage Fat Mass, Basal Metabolic Rate, visceral fat, and biological age estimation.
• EchoStudio Fragility Score Software module for independent assessment of internal bone structure quality, providing the patented Fragility Score (0-100) for bone fragility prediction based on microarchitectural spectral analysis.
• EchoStudio Fracture Risk Software module for assessment of 5-year fracture risk on lumbar vertebrae and femoral neck by combining BMD and Fragility Score for more accurate fracture prediction.
• EchoStudio Skeletal Software module for musculoskeletal ultrasound evaluations, paired with the Linear Probe for skeletal imaging applications.
• EchoStudio Gynecology Software module for gynecological ultrasound evaluations, paired with the Endocavity Probe for gynecological imaging applications.
• Convex Probe Convex ultrasound probe for abdominal ultrasound evaluations, providing wide-field imaging for general ultrasound applications.
• Linear Probe 40mm linear ultrasound probe matched with EchoStudio Skeletal software for musculoskeletal evaluations.
• Endocavity Probe Endocavity ultrasound probe matched with EchoStudio Gynecology software for gynecological evaluations.
• R.E.M.S. Technology (Radiofrequency Echographic Multi Spectrometry) Proprietary radiation-free ultrasound-based technology for assessing bone density and quality at lumbar vertebrae and proximal femur by analyzing radiofrequency signals acquired during scanning, characterizing bone microarchitecture and overcoming DXA and QUS limitations.

Quantifiable outcome

• Scan time of 40 seconds for femur and 80 seconds for spine with immediate reporting
• +4 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Partnerships

Six partnerships are on record, tiered flagship, notable and core.

• NASAflagshipStrategic or Co-development Partner · 1 January 2024NASA uses Echolight's proprietary REMS technology to monitor bone changes in human bedrest studies and assess effects of unloading on bone mass. This represents major validation of technology for space health applications where bone loss monitoring is critical for long-duration missions.
• UCSF Skeletal Health Service / UC Space HealthnotableStrategic or Co-development Partner · 1 January 2023Collaboration with UCSF (University of California, San Francisco) Skeletal Health Service and UC Space Health program for bone health research, including NASA's space health applications. Prof. Aenor Sawyer serves as advisor.
• KIWA CERMETnotableTechnology or Integration · 1 January 2023Notified body that certified EchoS, EchoStation, and EchoStudio products for CE marking and ISO certifications (ISO 13485:2012, ISO 13485:2003, ISO 9001:2008).
• International Scientific Advisory BoardcoreStrategic or Co-development Partner · 1 January 2016Echolight established an international scientific advisory board with the most important medical personalities in osteoporosis diagnosis to guide clinical development and validate technology applications.
• International Osteoporosis Reference CenterscoreStrategic or Co-development Partner · 1 January 2013Multi-center clinical validation studies conducted in the most important reference centers for osteoporosis diagnosis worldwide, involving more than 10,000 subjects and validating R.E.M.S. technology equivalence to DXA.
• Consiglio Nazionale delle Ricerche (CNR)coreStrategic or Co-development Partner · 1 January 2012Echolight originated as a spin-off from the Italian National Research Council. Ongoing collaboration with CNR includes joint clinical validation studies and the Clinical Scientist role that works at the interface with CNR researchers.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• BeamMed (Sunlight): Developer of Sunlight MiniOmni and related quantitative ultrasound (QUS) bone densitometry systems. Closely comparable as a direct ultrasound-based bone densitometry competitor targeting primary-care and portable use cases.
• OsteoSys: Korea-based manufacturer of QUS bone densitometry devices (Dexxum, Sonost series). Comparable as a direct ultrasound-based bone densitometry peer focused on portable, lower-cost screening solutions.

Regional players

• Furuno Electric: Japan-based manufacturer of CM-200 and other ultrasound-based bone densitometry systems. Comparable as a regional ultrasound bone density peer primarily serving Asian markets with limited direct competition to Echolight in Europe/US.

Broad incumbents

• Hologic: Dominant DXA-based bone densitometry vendor (Horizon series) with deep hospital and imaging-center penetration. Compares as the incumbent alternative whose installed base Echolight must displace or complement in clinical workflows.
• GE Healthcare: Maker of the Lunar DXA bone densitometry systems (iDXA, Prodigy) used widely in hospitals and research centers. Comparable as the entrenched DXA competitor with extensive clinical evidence and global distribution.
• Siemens Healthineers: Major imaging equipment vendor (X-ray, ultrasound, MRI). Comparable as a broad incumbent with scale advantages and clinical channel access that any novel bone densitometry entrant must navigate.
• Swissray: Manufacturer of ddRCompact and other digital radiography/DXA systems used in bone health. Comparable as a broad imaging incumbent in the same clinical workflows where REMS competes.
• Philips Healthcare: Global imaging and healthcare technology major with ultrasound and diagnostic imaging portfolios. Comparable as a broad incumbent whose ultrasound platforms could be extended into bone densitometry applications.
• DMS (Diagnostic Medical Systems): French imaging company offering DXA (Stratos, Challenger) and ultrasound bone densitometry solutions. Comparable as a multi-modality bone-health imaging vendor with European distribution overlap.

Emerging players

• Medilink: Medical device distributor and bone densitometry solutions provider (often partnered with OsteoSys). Comparable as an adjacent channel and product peer in the ultrasound bone densitometry space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/EcholightSpa
• YouTubeyoutube.com/channel/UCtqIJZt6ruaci6l3ciBi45Q
• Facebookfacebook.com/echolightspa
• LinkedInlinkedin.com/company/echolight
• Instagraminstagram.com/echolightspa

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Echolight.it